AbbVie (ABBV) net income: $4.2B
AbbVie reported a net income of $4.2B for the year ended Dec 31, 2025, down 1.2% from $4.3B a year earlier.
From AbbVie's filings with the SEC · Read the filing · ABBV stock page
AbbVie net income by year
#110 of 3,748 US companies by net income · See the full ranking
| Year ended | Net income | Change |
|---|---|---|
| Dec 31, 2025 | $4.2B | -1% |
| Dec 31, 2024 | $4.3B | -12% |
| Dec 31, 2023 | $4.9B | -59% |
| Dec 31, 2022 | $11.8B | +3% |
| Dec 31, 2021 | $11.5B | – |
Net income of similar companies
Companies in the same industry as AbbVie, by SEC industry code, with the closest net income. Each name opens the same page for that company.
| Company | Net income, latest year | Year ended |
|---|---|---|
| Pfizer | $7.8B | Dec 31, 2025 |
| Bristol Myers Squibb | $7.1B | Dec 31, 2025 |
| Abbott Laboratories | $6.5B | Dec 31, 2025 |
| Regeneron Pharmaceuticals | $4.5B | Dec 31, 2025 |
| AbbVie | $4.2B | Dec 31, 2025 |
| Vertex Pharmaceuticals Inc / Ma | $4B | Dec 31, 2025 |
| Zoetis | $2.7B | Dec 31, 2025 |
Questions and answers
What is AbbVie's net income?
AbbVie reported a net income of $4.2B for the year ended Dec 31, 2025, down 1.2% from $4.3B a year earlier.
Numbers as reported in AbbVie's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology